Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	138
Overall Study	STARTED	Crofelemer 125 mg	136
Overall Study	STARTED	Crofelemer 250 mg	54
Overall Study	STARTED	Crofelemer 500 mg	46
Overall Study	COMPLETED	Placebo	129
Overall Study	COMPLETED	Crofelemer 125 mg	126
Overall Study	COMPLETED	Crofelemer 250 mg	54
Overall Study	COMPLETED	Crofelemer 500 mg	40
Overall Study	NOT COMPLETED	Placebo	9
Overall Study	NOT COMPLETED	Crofelemer 125 mg	10
Overall Study	NOT COMPLETED	Crofelemer 250 mg	0
Overall Study	NOT COMPLETED	Crofelemer 500 mg	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00547898/flow